NCT02813317

Brief Summary

This prospective, multicenter, observational study aims to explore a comprehensive approach to the care of early breast cancer patients in a regional health territory (including 1.5 million women and characterized by a breast cancer incidence and mortality higher than national ranges), incorporating all healthcare actors inside and outside the hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
617

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2014

Typical duration for all trials

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 6, 2016

Completed
6 months until next milestone

First Posted

Study publicly available on registry

June 27, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

April 13, 2017

Status Verified

April 1, 2017

Enrollment Period

2.2 years

First QC Date

January 6, 2016

Last Update Submit

April 12, 2017

Conditions

Keywords

SurgeryBreast cancerQuality of lifeCare pathwayEconomic evaluation

Outcome Measures

Primary Outcomes (4)

  • Care pathways description of early breast cancer patients.

    Care pathways will be characterized by the sequence of different care steps. Care steps may include : outpatient surgery, home hospitalization, a one-stop breast clinic visit, care by an oncology pivot nurse and/or screening for supportive care.

    Up to one year after patient registration

  • Overall cost measurements of the different care pathways.

    Evaluating the overall costs of the pathway care (health care and supportive care consumption) at one year for the different perspectives.

    Up to one year after patient registration

  • Overall cost measurements of the different care pathways for health insurance

    Evaluating the indirect costs of health insurance

    Up to one year after patient registration

  • Overall cost measurements of the different care pathways for the patient

    Evaluating the out-of-pocket health expenses for breast cancer during the first year post diagnosis (direct and indirect costs).

    Up to one year after patient registration

Secondary Outcomes (10)

  • Patient satisfaction evaluation

    Up to one year after patient registration.

  • Supportive care needs assessement

    Up to one year after patient registration

  • Supportive care needs assessement

    Up to one year after patient registration

  • Breast cancer impact on patient's professional activity

    Up to one year after patient registration.

  • Breast cancer impact on patient's professional activity

    Up to one year after patient registration.

  • +5 more secondary outcomes

Other Outcomes (1)

  • Care pathways suggestion for a regional health territory.

    Through study completion (within one year after the last patient follow-up)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Previously untreated, operable breast cancer.

You may qualify if:

  • Signed written informed consent.
  • Patients aged ≥18 years.
  • Previously untreated, operable breast cancer
  • Affiliation with the social security system (or a similar coverage)
  • Patient living in one of these french department : "Hauts-de-Seine (92)", "les Yvelines (78)", or "le Val d'Oise (95)".
  • Female gender.

You may not qualify if:

  • Previous history of breast cancer.
  • Metastatic, locally advanced, or inflammatory breast cancer, as defined by the AJCC (American Joint Committee on Cancer, 7th Edition).
  • Any prior treatment for primary breast cancer.
  • Patient with any psychological, sociological or geographical condition potentially hampering compliance with the study follow-up schedule.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Victor Dupouy Hospital

Argenteuil, 95100, France

Location

Antoine Béclère Hospital

Clamart, France

Location

Louis Mourier Hospital

Colombes, 92700, France

Location

André Mignot Hospital - Versailles

Le Chesnay, 78150, France

Location

Institut Curie

Paris, 75005, France

Location

Bichat Beaujon University Hospital

Paris, 75018, France

Location

Poissy Interegional Hospital Center

Poissy, 78300, France

Location

René Dubos Hospital

Pontoise, 95000, France

Location

Institut Curie - René Huguenin Hospital

Saint-Cloud, 92210, France

Location

Related Publications (1)

  • Arfi A, Baffert S, Soilly AL, Huchon C, Reyal F, Asselain B, Neffati S, Rouzier R, Hequet D. Determinants of return at work of breast cancer patients: results from the OPTISOINS01 French prospective study. BMJ Open. 2018 May 18;8(5):e020276. doi: 10.1136/bmjopen-2017-020276.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Roman ROUZIER, Pr

    Institut Curie

    STUDY DIRECTOR
  • Delphine HEQUET, MD PhD

    Institut Curie

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 6, 2016

First Posted

June 27, 2016

Study Start

December 1, 2014

Primary Completion

February 1, 2017

Study Completion

April 1, 2017

Last Updated

April 13, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations